118 related articles for article (PubMed ID: 26875789)
1. Insights from Analysis of Binding Sites of Human Meprins: Screening of Inhibitors by Molecular Dynamics Simulation Study.
Chaudhuri A; Bera AK; Sarkar I; Chakraborty S
Comb Chem High Throughput Screen; 2016; 19(3):246-58. PubMed ID: 26875789
[TBL] [Abstract][Full Text] [Related]
2. Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.
Kruse MN; Becker C; Lottaz D; Köhler D; Yiallouros I; Krell HW; Sterchi EE; Stöcker W
Biochem J; 2004 Mar; 378(Pt 2):383-9. PubMed ID: 14594449
[TBL] [Abstract][Full Text] [Related]
3. Structure and Dynamics of Meprin β in Complex with a Hydroxamate-Based Inhibitor.
Linnert M; Fritz C; Jäger C; Schlenzig D; Ramsbeck D; Kleinschmidt M; Wermann M; Demuth HU; Parthier C; Schilling S
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073350
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of binding sites of human meprins with hydroxamic acid derivative by molecular dynamics simulation study.
Chaudhuri A; Sarkar I; Chakraborty S
J Biomol Struct Dyn; 2014 Dec; 32(12):1969-78. PubMed ID: 24279637
[TBL] [Abstract][Full Text] [Related]
5. Tertiary-Amine-Based Inhibitors of the Astacin Protease Meprin α.
Tan K; Jäger C; Schlenzig D; Schilling S; Buchholz M; Ramsbeck D
ChemMedChem; 2018 Aug; 13(16):1619-1624. PubMed ID: 29927060
[TBL] [Abstract][Full Text] [Related]
6. Exploring protein-protein intermolecular recognition between meprin-α and endogenous protease regulator cystatinC coupled with pharmacophore elucidation.
Chaudhuri A; Biswas S; Chakraborty S
J Biomol Struct Dyn; 2019 Feb; 37(2):440-453. PubMed ID: 29343185
[TBL] [Abstract][Full Text] [Related]
7. Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold-Hopping Approach.
Tan K; Jäger C; Körschgen H; Geissler S; Schlenzig D; Buchholz M; Stöcker W; Ramsbeck D
ChemMedChem; 2021 Mar; 16(6):976-988. PubMed ID: 33369214
[TBL] [Abstract][Full Text] [Related]
8. Mannan-binding protein blocks the activation of metalloproteases meprin alpha and beta.
Hirano M; Ma BY; Kawasaki N; Okimura K; Baba M; Nakagawa T; Miwa K; Kawasaki N; Oka S; Kawasaki T
J Immunol; 2005 Sep; 175(5):3177-85. PubMed ID: 16116208
[TBL] [Abstract][Full Text] [Related]
9. The metalloproteases meprin α and meprin β: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis.
Broder C; Becker-Pauly C
Biochem J; 2013 Mar; 450(2):253-64. PubMed ID: 23410038
[TBL] [Abstract][Full Text] [Related]
10. First insight into structure-activity relationships of selective meprin β inhibitors.
Ramsbeck D; Hamann A; Schlenzig D; Schilling S; Buchholz M
Bioorg Med Chem Lett; 2017 Jun; 27(11):2428-2431. PubMed ID: 28408220
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore modeling coupled with molecular dynamic simulation approach to identify new leads for meprin-β metalloprotease.
Chaudhuri A; Hudait N; Chakraborty SS
Comput Biol Chem; 2019 Jun; 80():292-306. PubMed ID: 31054542
[TBL] [Abstract][Full Text] [Related]
12. Continuous assays for meprin alpha and beta using prolyl tripeptidyl aminopeptidase (PtP) from Porphyromonas gingivalis.
Schulze A; Wermann M; Demuth HU; Yoshimoto T; Ramsbeck D; Schlenzig D; Schilling S
Anal Biochem; 2018 Oct; 559():11-16. PubMed ID: 30098994
[TBL] [Abstract][Full Text] [Related]
13. A kinetic comparison of the homologous proteases astacin and meprin A.
Wolz RL
Arch Biochem Biophys; 1994 Apr; 310(1):144-51. PubMed ID: 8161197
[TBL] [Abstract][Full Text] [Related]
14. Human and mouse homo-oligomeric meprin A metalloendopeptidase: substrate and inhibitor specificities.
Bylander JE; Bertenshaw GP; Matters GL; Hubbard SJ; Bond JS
Biol Chem; 2007 Nov; 388(11):1163-72. PubMed ID: 17976009
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of pyrazole-based inhibitors of meprin α and β.
Tan K; Jäger C; Geissler S; Schlenzig D; Buchholz M; Ramsbeck D
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2165648. PubMed ID: 36661029
[TBL] [Abstract][Full Text] [Related]
16. Discovery of dual-target natural inhibitors of meprins α and β metalloproteases for inflammation regulation: pharmacophore modelling, molecular docking, ADME prediction, and molecular dynamics studies.
Eltaib L; Alzain AA
SAR QSAR Environ Res; 2023 Nov; ():1-23. PubMed ID: 37955603
[TBL] [Abstract][Full Text] [Related]
17. Fetuin-A and cystatin C are endogenous inhibitors of human meprin metalloproteases.
Hedrich J; Lottaz D; Meyer K; Yiallouros I; Jahnen-Dechent W; Stöcker W; Becker-Pauly C
Biochemistry; 2010 Oct; 49(39):8599-607. PubMed ID: 20806899
[TBL] [Abstract][Full Text] [Related]
18. Origin and Diversification of Meprin Proteases.
Marín I
PLoS One; 2015; 10(8):e0135924. PubMed ID: 26288188
[TBL] [Abstract][Full Text] [Related]
19. Processing of procollagen III by meprins: new players in extracellular matrix assembly?
Kronenberg D; Bruns BC; Moali C; Vadon-Le Goff S; Sterchi EE; Traupe H; Böhm M; Hulmes DJ; Stöcker W; Becker-Pauly C
J Invest Dermatol; 2010 Dec; 130(12):2727-35. PubMed ID: 20631730
[TBL] [Abstract][Full Text] [Related]
20. The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases.
Sylte I; Dawadi R; Malla N; von Hofsten S; Nguyen TM; Solli AI; Berg E; Adekoya OA; Svineng G; Winberg JO
PLoS One; 2018; 13(8):e0200237. PubMed ID: 30075004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
